BCL2 and acute myeloid leukemia: In CLL patients, multiple mutations of Bcl-2 are related to the occurrence of acquired drug resistance, such as Gly101Val, D103Y, Phenol04Ile, Gly33Arg 20, 21, which proved to be unrelated to ABT199 resistant in AML 22.